Acute Management of Paroxysmal Atrial Fibrillation with Intravenous Flecainide plus Oral Beta-Blockers

Background: Intravenous (IV) flecainide is recommended for the pharmacological cardioversion of recent-onset atrial fibrillation (AF). The aim of this study was to study the efficacy and safety of IV flecainide, co-administered with oral b-blockers, for the cardioversion of paroxysmal AF. Methods: S...

Full description

Bibliographic Details

Published in:	International Journal of Translational Medicine
Main Authors:	Athanasios Kartalis, Dimitrios Afendoulis, Petros Voutas, Maria Moutafi, Nikolaos Papagiannis, Stefanos Garoufalis, Nikolaos Kartalis, Nikolaos Smyrnioudis, Antonios Ziakas, Matthaios Didagelos
Format:	Article
Language:	English
Published:	MDPI AG 2024-06-01
Subjects:	flecainide b-blocker atrial fibrillation paroxysmal cardioversion
Online Access:	https://www.mdpi.com/2673-8937/4/2/21